Requirements for the establishment of productive infection with the human immunodeficiency virus type 1 (HIV-1) in primary monocytes were investigated. In vitro, monocytes rendered susceptible for infection after at least a 2-d culture, but when cultured in the presence of differentiation-inducing agent IL-4, accelerated susceptibility was seen. Complete resistance to HIV-1 infection was observed in monocytes that had been treated for 5 d with rIL4, and comparable results were obtained with other differentiation inducers such as dexamethasone or 1,25(OH)2 vitamin D3 (1,25(OH)2vitD3). The inhibition of productive infection was not caused by downregulation of CD4 expression or HIV-1 transcription, nor by intracellular accumulation of virions. Since treatment with rIL4, dexamethasone, or 1,25(OH)2vitD3 also resulted in complete inhibition of monocyte proliferation, we studied whether establishment of productive infection in monocytes is proliferation dependent. Irradiation or mitomycin-C treatment within 24 h after inoculation prevented productive HIV-1 infection of monocytes, suggesting a proliferation-dependent step early in the virus replication cycle. Polymerase chain reaction (PCR) analysis revealed the presence of only incomplete proviral DNA species in nonproliferating monocytes, indicating restriction of viral replication at the level of reverse transcription. Thus, in analogy with HIV-1 infection of CD4+ T cells, proliferation of monocytes during differentiation into macrophages is a prerequisite for productive infection with HIV. (J. Clin. Invest. 1992Invest. .89:1154Invest. -1160
Introduction
It is now well established that monocytotropic HIV-1 variants and cells of the monocyte/macrophage lineage play an important role in the course of HIV-1 infection (1) (2) (3) (4) . The presence of monocytotropic HIV-1 variants during all stages of HIV-l infection (4, 5) suggests a role in persistence, whereas the finding that macrophages are the predominantly HIV-l-infected cells in tissue (1, 5) indicates a role for these cells in dissemination ofthe virus. However, peripheral blood monocytes or their bone marrow precursors only seldom harbor the virus (6) (7) (8) , suggesting that susceptibility to HIV-l infection is dependent on a certain state of differentiation. Treatment of promonocytic cell lines with differentiation-inducing agents resulted in enhanced susceptibility for monocytotropic HIV-l variants (9) , and several soluble factors or cytokines that regulate HIV-I expression have been described (10) (11) (12) (13) (14) .
Recently, requirements for the establishment ofproductive HIV-I infection in T cells were reported (15, 16) . Normal entry of virions in quiescent T cells was demonstrated, but productive infection was only established after induction ofcell proliferation (15) .
In this study we investigated the cellular requirements for the establishment of a productive infection in monocytes. We demonstrate that in monocytes HIV-l infection is also replication dependent in a manner comparable to T cells, and we show that induction of terminal differentiation renders monocytes refractory to HIV-l infection.
Methods
Cell isolation and culture. Monocytes were prepared from PBMC of HIV-seronegative plasmapherese donors, as described (17) , and cultured in vitro as monocyte-derived macrophages (MDM).' In brief, P$MC were obtained from venous blood by isolation on a percoll density gradient, and the monocyte fraction was purified (> 95% pure) by centrifugal elutriation. The virtual absence ofT cells in this population was demonstrated by the lack of [3H]thymidine incorporation in these cells above background levels, upon stimulation with phytohaemaglutinin. Monocytes were cultured for 5 d at a concentration of 106 monocytes/ml in endotoxin-free (1 1) Iscove's modified Dulbecco's medium (IMDM) supplemented with 10% pooled human serum, penicillin (100 U/ml), and streptomycin (100 yg/ml). Cells were plated in 96 well plastic tissue culture plates (Nunc, Roskilde, Denmark) (100 'd/ well), and maintained at 37°C in a humidified atmosphere supplemented with 5% CO2. Cultures were kept for 2 to 3 wk, and medium was changed every 7 d.
Virus. For cell-free infection of MDM, the monocytotropic virus HIV-I Ba-L (a kind gift ofDr. M. Popovic, NCI, Bethesda, MD), originally obtained from a lung biopsy from a boy with HIV-l-related lymphoid interstitial pneumonia, was used. MDM cultures were infected at day 5 of culture, unless indicated otherwise. After 24 h, unabsorbed virus and residual nonadherent cells were removed by washing. MDM were further cultured in the medium described above.
Virus detection. Virus production was assessed in a p24 antigen capture ELISA (18) . Triton X-100-treated culture supernatant samples were added to microtiter plates (Nunc) coated with a monoclonal antibody to p24 shown to recognize all HIV isolates (18) . After washing, bound p24 was detected with horseradish peroxidase-labeled antip24 rabbit IgG, followed by the addition ofthe substrate TMB (3,5,3',5' tetramethyl benzidine; Sigma Chemical Co., St. Louis, MO). A culture was considered positive when extinction was over two times the negative control.
Cytokines and other agents. Recombinant IL-la (5 ng/ml) was from Hoffmann-La Roche Inc. (Nutley, NJ); LPS (Escherichia coli; 055:B5) was obtained from Sigma Chemical Co., rIL-6 was produced in E. coli and purified by means of affinity chromatography, followed by gel filtration (19) . The specific activity of rIL-6 was 109 U/mg. rIL-3 (10 ng/ml) (20, 21) was from Gist-brocades (Delft, the Netherlands). Recombinant IL-4 (rIL-4) (50 ng/ml), recombinant tumor necrosis factor (rTNFa) (5 ng/ml) and recombinant granulocyte macrophage-colony stimulating factor (rGM-CSF) (100 U/ml) were from Sandoz Ltd. (Basel, Switzerland). Polyclonal antisera against rIL-4 were raised in sheep, and kindly provided to us by Dr. L. A. Aarden (Department of Autoimmune Diseases, CLB, Amsterdam). For both the transfection experiments and the virus production experiments, monocytes were cultured for 5 d before infection or transfection in the presence of the cytokines to be tested.
To analyze the effect of mitomycin-C or irradiation, cells were cultured for 5 d in the absence or presence of rIL-3 or rGM-CSF. 30 min before infection with HIV-1, or 3, 6, 12, 24, or 48 h after inoculation, cultures were treated with mitomycin-C (200 ug/ml) (Janssen Pharmaceutica, Beerse, Belgium) or irradiated (5,000 rad). After a 30-min mitomycin-C treatment, cells were thoroughly washed.
RNA isolation and Northern blot analysis. MDM cultured for 5 d in the presence of the cytokine to be tested were harvested. Total RNA of 50 X 106 cells/treatment was extracted with 4 M guanidine isothiocyanate, followed by centrifugation in 5.7 M CsCl. Total RNA from 25 X 106 was separated on a 1% agarose-formaldehyde gel, and transferred to Gene-screen Plus membranes (Du Pont Co. Diagnostic and Biosearch Systems, Wilmington, DE). Hybridizations were performed with probes radiolabeled by the random primer method.
Transfection and CA Tassays. Primary MDM were transfected, using the electroporation method (22) . In brief, purified monocytes were cultured in the presence or absence of the cytokines under study. At day 5, cells were harvested after 5 min incubation in 5 mM EDTA by gentle scraping with a rubber policeman, and then washed and resuspended in RPMI supplemented with 20% FCS to a final concentration of 2 X I07 cells/ml. For each transfection, 10 ,g of each plasmid DNA was used. The long-terminal repeat-chloramphenicol acetyltransferase (LTR-CAT) construct and the SV-tat plasmid construct (a kind gift from Dr. A. B. Rabson, National Institute of Allergy and Infectious Diseases, Bethesda, MD) (23) were cotransfected to increase the level of CAT expression. The construct containing two nuclear factor (NF)-kB binding sites linked to the thymidine kinase promoter was a gift from Dr. Baltimore (Whitehead Institute, Boston, MA) (24) . Before transfection, cells were placed on ice for 10 min. Cells were electroporated in disposable cuvettes (Bio-Rad Laboratories, Richmond, CA) at 250 V, 960 MuF. After transfection, cells were placed on ice again for 10 min, and then plated in a final concentration of 2 x 106 cells/ml in MDM medium, as described above. 24 h after transfection, cell extracts were prepared for CAT assay.
Proliferation assay. Cytokine-induced monocyte proliferation was onstrated that by use ofthis method, as few as two proviral DNA copies in a DNA equivalent of 5 x I05 cells can be detected (25) . The PCR for amplification of the R/U5 region is less sensitive, and detects 100-1,000 proviral DNA copies in a DNA equivalent of 5 X I05 cells. Monocytes were cultured for 5 d in the absence or presence ofrIL-3 (10 ng/ml), rIL-4 (50 ng/ml), or a combination thereof. The inoculum (HIV-l Ba-L) was DNase (200 ng/ml) (RQ1; Promega Corp., Madison WI) treated for 30 min in medium containing 6 mM MgCI2, and then filtrated through a 0.22-Am filter. As a control, a heat-inactivated (HI-HIV; 1 h, 560C) inoculum was used. 24 h after inoculation, cells were carefully washed, and DNA was extracted from 106 cells and finally solved in 100 Ml water. For each analysis, 5 Al ofthe DNA solution was used in the first step of a two-step nested PCR (25) , and 1 Ml of the product of the first-step PCR is used in the second-step PCR. This results in the amplification ofa conserved 125-bp sequence ofthe HIV-1 pol region. MgCl2 concentrations are 1.5 mM in the first step, and 1.0 mM in the second step. Primers used in the first step: 5'TTA. (15) was performed identical to the amplification cycles of the first step in the pol amplification, also with 5 Ml DNA solution.
Amplified DNA was separated on a polyacrylamide gel, blotted to Zeta-probe filter, and hybridized to an internal probe. For pol the 4373-bp to 4404-bp fragment was used; for the R/U5 the 9606-bp to 9631-bp fragment was used. PCR analysis of ,B-globine demonstrated the presence of DNA in all samples (data not shown).
Results
Inhibition ofHIV-I replication in primary infected monocytes. Highly purified peripheral blood monocytes were inoculated with HIV-l Ba-L on days 0 to 5 ofculture. Productive infection could only be demonstrated in monocytes inoculated after at least 2 d of culture (Fig. 1 a) . Thus, differentiation induced by plastic adherence rendered monocytes susceptible to HIV-1 infection (2) . Treatment with IL-4, an inducer of differentiation (26) , resulted in accelerated susceptibility to HIV-1 infection, compared with untreated monocytes (Fig. 1 b) . However, complete resistance to HIV-1 infection was observed in monocytes Peak production at day 14 after inoculation is shown. Results are the mean of 12 replicates and representative for three independent experiments.
that had been treated for 5 d with rIL-4. Apparently, accelerated differentiation induced by rIL-4 limits the susceptibility of monocytes for HIV-l infection to a discrete window phase between day 1 and 5 of culture.
A dose-dependent inhibitory effect of 5-d rIL-4 treatment, with complete inhibition at a concentration of 50 ng/ml, could be demonstrated (Fig. 2 a) . In order to confirm that the observed inhibition was due to IL-4 and not caused by a toxic contaminant in the preparation, rIL-4 was either heat inactivated for 30 min at 1000C (data not shown), or preincubated with a neutralizing anti-IL-4 serum (Fig. 2 b) before addition to the cultures. In all experiments (n = 3), IL-4-induced inhibition of HIV-1 expression was completely abrogated in both protocols. IL-4 had to be present during the first 5 d of culture to establish its inhibitory effect. Addition ofIL-4 to the cultures at day 5, after inoculation, had no effect (data not shown). Furthermore, the inhibitory effect of IL-4 was cell-type specific, since virus production in PBL was enhanced by IL-4 (data not shown). Next to inhibition ofHIV-1 production by rIL-4 of otherwise untreated MDM, the effect ofthis cytokine was analyzed in combination with cytokines known to enhance HIV expression in monocytes (10, 11, 13) . MDM pretreated with rIL-1, rIL-3, rGM-CSF, or rTNF-a showed enhanced HIV-1 expression, as compared with untreated controls. However, when these cytokines were used in combination with rIL-4, all cultures remained negative for virus production (Fig. 3) .
Inhibition ofproductive HIV-1 infection is not caused by down modulation of CD4 expression. CD4, the receptor for HIV-1, is expressed at a very low level on MDM (27) . FACS analysis demonstrated comparable low levels of CD4 expression on both 5-d cultured control cells and IL-4-treated cells (data not shown). Due to the very low expression, however, down modulation ofCD4 by IL-4 as a mechanism ofinhibition can hardly be quantified by analysis of membrane expression.
To further study whether IL-4 performs its inhibitory effect by down modulation of CD4 expression, mRNA levels for CD4 were compared for rIL-4-treated and untreated cells. No differences in the amounts of CD4-specific mRNA in treated or untreated cells were observed (Fig. 4 a, lanes 1 and 2) , other than due to differences in the total amount of mRNA (Fig. 4) . rIL-l, rIL-3, rIL-6, GM-CSF, or TNFa also did not demonstrate any decrease in the level of CD4 mRNA (Fig. 4 a, lanes  3-12) . Inhibition ofproductive HIV-I infection occurs at apretranscriptional level. Inhibitory effects of IL-4 on the expression of IL-6, IL-1, and TNFa in monocytes have been reported (28, 29) . These cytokines induce activation of NF-kB (30, 31) or NF-kB-like factors. Since the expression of both HIV-1 (24) and these cytokines (32, 33) is believed to be predominantly regulated by NF-kB, we tested whether the mechanism of action by which rIL-4 inhibits HIV-l expression was at the transcriptional level, in particular, by inhibition of NF-kB activation.
This was investigated in a transient expression system in which transcriptional activity under control ofthe HIV-1-LTR was studied. Pretreatment with either rIL-l, rIL-3, TNFa, or rGM-CSF resulted in activation ofthe HIV-LTR. IL-4 did not inhibit LTR-driven CAT activity. On the contrary, the strongest induction of LTR-driven CAT activity was seen in MDM cultured with rIL-4 alone, or with combinations of IL-4 with other cytokines (Fig. 4 a) . Comparable results were obtained when the NF-kB-CAT construct was used, demonstrating that the HIV-1 LTR activity was associated with induction of NFkB (Fig. 4 b) .
Since virus could not be rescued upon lysis of the IL-4- 5 (Fig. 6 a) . In the presence of IL-4, comparable kinetics of the proliferative response were seen during the first 4 (Fig. 7 a) , even when a combination with GM-CSF was used (Fig. 7 b) . The role of monocyte proliferation was further analyzed in a differentiation-independent fashion by use ofthe antimitotic agent mitomycin-C. A 30-min treatment with mitomycin-C of monocytes that had been precultured for 5 d resulted in complete inhibition ofboth proliferation and HIV-l infection (Fig.  8) . Prevention of HIV-l infection by mitomycin-C treatment was effective until 24 h after inoculation, but not thereafter, suggesting a block early in the replication cycle (Fig. 7) . Addition of mitomycin-C 48 h after inoculation had no effect, excluding toxic side effects of the drug. Comparable results were obtained when proliferation was blocked by gamma irradiation (5,000 rad; data not shown). in the presence of IL-I (5 ng/ml), IL-3 (10 ng/ml), GM-CSF (100 U/ ml), TNF-a (5 ng/ml), either alone or in combination with rIL-4 (50 ng/ml). Data represent three independent experiments. As a quantitative control for the total amount of RNA, a r-actin probe was used.
duction of terminal differentiation, a 5-d treatment of monocytes with rIL-4 resulted in complete inhibition ofproliferation (Fig. 6 b) . Similar results were obtained when IL-4 was used in combination with IL-3 (data not shown).
To analyze whether the inhibitory effect on both productive HIV-1 infection and proliferation was indeed due to the induction of terminal differentiation, other differentiation-in- a region in the pol gene, reverse transcription of which occurs late in provirus formation. In nonproliferating macrophages inoculated with HIV-1 Ba-L, proviral DNA could not be detected with the primer pair specific for a fragment in the pol gene, indicating the absence of complete provirus (Fig. 9) . However, amplification ofthe R/U5 region was successful, confirming the presence of incomplete DNA species (Fig. 9) . Thus, similar to resting T cells, in nonproliferating macrophages the block in the infection cycle is at the level of reverse transcription (15). In this study we investigated the cellular requirements for HIV-1 infection in primary monocytes. The low frequency of HIVl-harbouring monocytes in the peripheral blood compartment (6) , and the finding that macrophages are the predominantly infected cells in tissues suggests that monocytes become susceptible for HIV-l infection relatively late in their ontogeny. This hypothesis was supported by the finding that freshly isolated Previously, we and others demonstrated low levels ofproliferation in monocytes that could be enhanced by the addition of IL-3 or GM-CSF (10, 14, 34) . IL-4 treatment of monocytes resulted in a complete proliferation block concomitant with the induction of differentiation. Recently, productive HIV-1 infection of T cells was shown to be proliferation dependent (15, 16) . Here we demonstrated that differentiation-independent inhibition of proliferation by mitomycin-C treatment or irradiation also renders monocytes refractory to HIV-1 infection. Moreover, in complete analogy to quiescent T cells (15) , in nonproliferating monocytes only incomplete DNA species could be demonstrated, indicating a block at the level ofreverse transcription.
In quiescent T cells, the incomplete HIV-I DNA structure is considered to be an intermediate latent form that can become activated upon subsequent stimulation of T cells. In these activated cells, reverse transcription might be completed, resulting in productive infection. In IL-4-treated terminally differentiated macrophages inoculated with HIV-1, neither proliferation nor virus production could be induced by treatment with IL-3 or GM-CSF (data not shown). Therefore, in contrast to resting T cells, the incomplete HIV-l DNA species in macrophages probably represents a dead-end product, rather than a latent form.
These experiments demonstrate that the cellular requirements for HIV-1 infection ofmonocytes and T cells are remarkably similar, although the two cell types probably have very different roles in the pathogenic process underlying the progression to AIDS. HIV-I infection in monocytes has been considered to be proliferation independent (1). Susceptibility for HIV-1 infection, however, decreases over time (36) , as does the proliferative capacity of monocytes in culture (14) . Here, due to enhanced terminal differentiation and concomitant with that, inhibition ofproliferation, the period during which monocytes are susceptible to HIV-1, is limited to a brief window period during differentiation into macrophages. Differentiation of monocytes in vivo most likely occurs after diapedesis, and is modulated during inflammatory responses by cytokines such as IL-4 or IL-6, which are released by activated T cells and monocytes, respectively. Intimate interaction between infected T cells and differentiating monocytes at this stage may provide an efficient mechanism for HIV-1 transmission. Subsequently, upon terminal differentiation, these infected macrophages in turn may function as a reservoir for infection of T cells. The high activity ofNF-kB in these terminally differentiated macrophages thus creates the optimal conditions for efficient virus production. Interestingly, our data on proliferation-dependent HIV-l infection in monocytes indicate that phagocytosis of HIV-1 particles or infected cells by mature macrophages will not result in productive HIV-1 infection.
Susceptibility for HIV-l infection has been reported for a variety of cell types next to T cells and cells of the monocyte/ macrophage lineage. Further study will have to reveal to what extent proliferative dependence is a feature of HIV-1 infection in these cell types.
